User: Guest  Login
Title:

Pegylated liposomal doxorubicin and carboplatin in advanced gynecologic tumors: a prospective phase I/II study of the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR).

Document type:
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Article
Author(s):
du Bois, A; Burges, A; Meier, W; Pfisterer, J; Schmalfeldt, B; Richter, B; Jackisch, C; Staehle, A; Kimmig, R; Elser, G
Abstract:
BACKGROUND: Single-agent platinum and single-agent pegylated liposomal doxorubicin (PLD) are both effective in the treatment of gynecologic malignancies. Based on evidence that combination platinum-containing regimens offer superior efficacy versus single-agent regimens, we conducted this study to determine the maximum tolerated dose (MTD) of PLD in combination with carboplatin. PATIENTS AND METHODS: In this phase I/II dose-finding study, six courses of PLD (20, 30, 40 or 50 mg/m2) and carboplat...     »
Journal title abbreviation:
Ann Oncol
Year:
2006
Journal volume:
17
Journal issue:
1
Pages contribution:
93-6
Language:
eng
Fulltext / DOI:
doi:10.1093/annonc/mdj032
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/16282248
Print-ISSN:
0923-7534
TUM Institution:
Frauenklinik und Poliklinik
 BibTeX